Current Progress in the Clinical Management and Basic Science of Head and Neck Cancer: 2nd Edition

Dear Colleagues,

This Special Issue is the second edition of a previous Issue on the topic of "Current Progress in the Clinical Management and Basic Science of Head and Neck Cancer”.

(https://www.mdpi.com/journal/cancers/special_issues/A5ID7807OL).

Every year, more than 800,000 patients are newly diagnosed with HNSCC worldwide, and approximately 450,000 patients die from the disease. Cigarette smoking, alcohol consumption, and viral infections are recognized as they major factors contributing to HNSCC. In addition to surgery and chemoradiotherapy, molecularly targeted therapies and immunotherapies have become the main treatment options for HNSCC. As both basic and clinical research in this field have rapidly progressed in recent years, it is increasingly important for clinicians to understand the underlying biology of HNSCC in order to select appropriate therapies in the emerging era of personalized medicine.

In this Special Issue of Cancers, we welcome original research articles and review papers addressing clinical advances in the treatment of HNSCC, as well as basic research on its carcinogenesis, tumor microenvironment and microbiome, and antitumor immunity. Reports of clinical experience or case series are also acceptable, provided they address particularly novel or clinically relevant topics within the field.

Dr. Takumi Kumai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.